Poria
Natural health product licensed in Canada
- Licence holder
- Pharmaplanter Technologies Inc.
- NPN or DIN-HM
- 80078794
- Status
- Active licence
- Licence date
- 29 June 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Wolfiporia extensa Source : Sclerotium Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,600 milligramme | 160 milligramme | Not calculated |
| Wolfiporia extensa Source : Sclerotium | Not specified | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Silice, Hypromellose, Cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Used in Herbal Medicine to support the immune system. Source of fungal polysaccharides with immunomodulating properties.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy can occur; in which case, discontinue use. Diuretic effect may occur.
Source
Official Health Canada record, licence 80078794
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.